SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-20-000131
Filing Date
2020-12-30
Accepted
2020-12-30 16:44:30
Documents
4
Period of Report
2020-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lumo-20201230x8k.htm 8-K 31799
2 EX-5.1 lumo-20201230x8kxex51.htm EX-5.1 11719
3 EX-10.1 lumo-20201230x8kxex101.htm EX-10.1 330655
4 image_01a.jpg GRAPHIC 68421
  Complete submission text file 0001126234-20-000131.txt   467703
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 201426361
SIC: 2834 Pharmaceutical Preparations